期刊文献+

植入式静脉输液港相关感染并发症风险因素分析 被引量:36

Implantable venous access port- related infection: analysis of its risk factors
下载PDF
导出
摘要 目的探讨植入式静脉输液港(IVAP)应用患者发生导管相关感染并发症的风险因素。方法收集2012年1月至2015年12月接受IVAP植入治疗的582例患者临床资料,对患者一般临床资料、细菌学资料、病情进展情况及IVAP相关感染发生率进行回顾性分析。结果 14例(2.4%,14/582)患者出现感染症状后取出IVAP,IVAP相关感染发生率为67例/千导管日。单因素分析显示住院患者(P=0.016)、恶性血液疾病患者(P=0.040)及接受姑息性化疗患者(P=0.022)感染率较高。多变量二元回归分析结果显示,恶性血液疾病及姑息性化疗患者发生感染的校正OR值分别为7.769(P=0.001)、4.863(P=0.003)。9例血液样本中细菌培养为阳性,最常见者为葡萄球菌(n=4)及念珠菌(n=2)。结论恶性血液病和姑息性化疗,可能是引起IVAP相关感染的独立危险因素。 Objective To investigate the incidence and risk factors of catheter-related infections in patients receiving implantable venous access port (IVAP). Methods A total of 582 patients, who received IVAP at authors' hospital during the period from January 2012 to December 2015, were included in this study. The general clinical data, bacteriological data, disease progression and the incidence of IVAP-related infections were retrospectively analyzed. Results IVAP device was removed in 14 patients (14/582, 2.4%) when they developed infection symptoms. The incidence of IVAP- related infections was 67 cases/1000 catheter-days. Univariable analysis showed that the infection rate was higher in the hospitalized patients (P= 0.016), in the patients with malignant hematologic diseases (P=0.040), and in the patients receiving palliative chemotherapy (P=0.022). Multivariate binary logistic regression analysis indicated that the adjusted OR values for infection rate in patients with malignant hematologic diseases and in patients receiving palliative chemotherapy were 7.769 (P=0.001) and 4.863 (P=0.003), respectively. Positive bacteria culture was confirmed in 9 patients, and the most causative organisms were staphylococcus (n=4) and candida (n= 2). Conclusion The underlying malignant hematologic diseases and the use of palliative chemotherapy may be the independent risk factors for IVAP-related infections.
出处 《介入放射学杂志》 CSCD 北大核心 2016年第11期949-953,共5页 Journal of Interventional Radiology
基金 国家自然科学基金(81560297)
关键词 植入式静脉输液港 肿瘤患者 感染 并发症 implantable venous access port tumor patient infection complication
  • 相关文献

参考文献3

二级参考文献49

  • 1许秀芳,李晓蓉,刘玉金.肿瘤介入护理学[M].北京:科学出版社,2011:32.
  • 2Patel M, Philip V, Fazel F, et al. Human immunodeficiencyvirus infection and chronic myeloid leukemia [J ]. LeukemiaResearch,2012,36(11) :1334-1338.
  • 3Madlambayan GJ,Bartee E,Kim al. Acute myeloid leu-kemia targeting by myxoma virus in vivo depends on cell bind-? ing but not permissiveness to infection in vitro[J]. LeukemiaResearch,2012,36(5) :619-624.
  • 4程永德,程英升,颜志平,等.常见恶性肿瘤介入治疗指南[M].北京:科学出版社,2013年.
  • 5Funakoshi T,Latif A,Galsky MD.Risk of hematologic toxicities in patients with solid tumors treated with everolimus:a systematic review and meta-analysis[J].Crit Rev Oncol Hematol,2013,88(1):30-41.
  • 6谢彩琴,赵锐祷,曹素娟.血液肿瘤患者PICC导管相关性感染的原因分析与护理对策[J].临床护理杂志,2012,32(8):33-37.
  • 7Niederhuber JE, Ensminger W, Gyves JW, et al. Totally implanted venous and arterial access system to replace external catheters in cancer treatment[J]. Surgery, 1982, 92: 706-712.
  • 8Kreis H, Loehberg CR, Lux MP, et al. Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies[J]. Eur J Surg Oncol, 2007, 33: 39-43.
  • 9Ignatov A, Hoffman O, Smith B, et al. An 11-year retrospective study of totally implanted central venous access ports: com- plications and patient satisfaction [J]. Eur J Surg Oncol, 2009, 35:241-246.
  • 10Ruesch S, Walder B, Tramer MR. Complications of central venous catheters: internal jugular versus subclavian access: a systematic review[J]. Crit Care Med, 2002, 30: 454-460.

共引文献144

同被引文献254

引证文献36

二级引证文献258

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部